SCHEMBL7167114

SCHEMBL7167114

CCOc1ccccc1C(=O)Nc1c(C(N)=O)cccc1C(N)=O

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.60
MAPK1 P28482 2/20 0.60
GAA P10253 2/20 0.60
KCNK3 O14649 3/20 0.60
KCNK9 Q9NPC2 3/20 0.60
HCRTR1 O43613 2/20 0.60
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
RAB9A P51151 1/20 0.56
ALOX15 P16050 1/20 0.55
KCNMA1 Q12791 1/20 0.54
TP53 P04637 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
RXFP1 Q9HBX9 1/20 0.53
LMNA P02545 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7160571 0.92 MAPT (0.55) MAPTMAPK1GAAKCNK3KCNK9
SCHEMBL7160516 0.92 KCNK3 (0.65) MAPTMAPK1GAAKCNK3KCNK9
Ethenzamide SCHEMBL25624 0.83 MAPT (0.68) MAPTMAPK1GAAHCRTR1MEN1
Ethenzamide SCHEMBL27612766 0.83 MAPT (0.68) MAPTMAPK1GAAHCRTR1MEN1
SCHEMBL7167278 0.82 MAPT (0.53) MAPTMAPK1GAAKCNK3KCNK9
Ethenzamide SCHEMBL4379591 0.81 MAPT (0.66) MAPTMAPK1GAAHCRTR1MEN1
Ethenzamide SCHEMBL22163775 0.81 MAPT (0.66) MAPTMAPK1GAAHCRTR1MEN1
Ethenzamide SCHEMBL5401172 0.81 MAPT (0.66) MAPTMAPK1GAAHCRTR1MEN1
SCHEMBL6332463 0.80 MAPT (0.54) MAPTMAPK1GAAKCNK3KCNK9
SCHEMBL2358299 0.80 HCRTR1 (0.73) MAPTMAPK1GAAKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
EP-0628032-B1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LTD (GB) 1998-05-13 EP disclosed
US-5482941-A Quinazolinone antianginal agents PFIZER INC. (US) 1996-01-09 US disclosed
EP-0628032-A1 QUINAZOLINONE ANTIANGINAL AGENTS Pfizer Limited (GB) 1994-12-14 EP disclosed
WO-1993012095-A1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LIMITED (GB) 1993-06-24 WO disclosed